H
3-epinephrine or H3-norepinephrine was administered to rabbits or patients treated with reserpine, α-methyl DOPA, nialamide and dexamethasone, and the following findings were observed.
(1) In rabbits pretreated with reserpine, the myocardial level of H
3-epinephrine was significantly lower, but plasma level of it was only slightly lower than that of the control. Furthermore, in one patient suffering from essential hypertension treated with reserpine, the plasma level of H
3-epinephrine and the rate of disappearance of it from plasma were almost similar to that of the control patient.
(2) In rabbits pretreated with α-methyl DOPA, the contents of H
3-epinephrine in plasma and myocardium were significantly lower. However, that of H
3-metanephrine and H
3-acidic metabolites in both plasma and myocardium were not significantly lower or unchanged. With regard to H
3-norepinephrine, the similar findings were obtained. The rate of disappearance of H
3-epinephrine was more rapid in rabbits and patients treated with α-methyl DOPA, while that of its metabolites was not different from the control. The urinary excretion of H
3-epinephrine and its metabolites was lower than that of the control.
(3) In the group pretreated with α-methyl DOPA in combination with reserpine, the myocardial level and also the plasma level of H
3-epinephrine were lower.
(4) In rabbits pretreated with nialamide or dexamethasone, the levels of H
3-epinephrine and its metabolites in plasma and myocardium were all lower than that of the control, except for the level of H3-metanephrine in myocardium. Especially, the change in plasma was more prominent than that in myocardium.
(5) From the results of clinical studies in 5 patients, it seemed that there was no correlation between the level of plasma H
3-epinephrine and the degree of hypertensive or heart rate increasing response to H
3-epinephrine, and that the hypertensive response to H
3-epinephrine was greater in hypertensive patients than in non-hypertensive patients.
抄録全体を表示